ANDA 220857, held by Anthea Pharma. Propofol.
As of Nov 13, 2026, ANDA 220857 (Propofol), held by Anthea Pharma, was first approved by FDA on Jul 14, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 14, 2026 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Propofol10MG/ML ยท injectable;injection | Propofol | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
